Buy Strattera from Canada

$150.99 – $289.99

Strattera is available in capsule form with varying doses, including 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg, to accommodate patients’ varied needs and allow for dose adjustments based on efficacy and tolerability. Its effect in increasing norepinephrine levels in the brain can contribute to an improvement in ADHD symptoms, including better attention span and decreased impulsivity and hyperactivity.

10 MG
18 MG
25 MG
40MG
60 MG
80 MG
100 MG

Capsules

28 Capsules

Quantity:

Compare

SKU: N/A Category: Medications

Description
Additional information

Description

Strattera, known by its generic name atomoxetine, is a non-stimulant medication primarily used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. Unlike many traditional ADHD medications, Strattera is not a stimulant but works by selectively inhibiting the reuptake of norepinephrine, a neurotransmitter, thereby increasing its availability in the brain. This action helps improve attention, concentration, and reduces impulsivity and hyperactivity in individuals with ADHD. Its non-stimulant nature makes it a preferred option for patients who may not respond well to stimulant medications or those with a history of substance misuse.

Additional information

Usage	Indications: ● Primary Indication: Management of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. Administration Guidelines Dosage ● The dosage of Strattera is typically personalized, starting at a lower dose and gradually increasing to the optimal dose as directed by a healthcare professional. Method of Administration ● Strattera capsules should be swallowed whole with water or other liquids. They should not be opened, crushed, or chewed. It can be taken with or without food, although taking it with food may reduce potential stomach upset. Dosage Form ● Atomoxetine (Strattera) is available in capsule form for oral administration. Safety Preclusions Pregnancy and Breastfeeding ● Strattera is classified under FDA pregnancy category C. This indicates that its use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Caution is advised when Strattera is administered during breastfeeding. Long-term Use ● Healthcare professionals should periodically review long-term use of Strattera to assess its effectiveness and tolerability in managing ADHD symptoms. Drug Interactions ● Strattera should be used cautiously with medications that increase blood pressure or heart rate and with those that affect the norepinephrine system. Inform your healthcare provider about all medications being taken to avoid potential interactions.
Side Effects	● Usual side effects include stomach upset, nausea, decreased appetite, dizziness, mood swings, and difficulty sleeping. Serious Side Effects ● More severe reactions may include liver damage, heart-related problems, and psychiatric symptoms like suicidal thoughts, especially in the initial few months of treatment or after a dose adjustment.
Storage	● Strattera capsules should be stored at room temperature, between 15°C to 30°C (59°F to 86°F), away from moisture and heat. Keep the medication in a secure place away from children.
Special Precautions	● Monitoring is recommended for growth in children, blood pressure, heart rate, and for signs of suicidal ideation or unusual behavioral changes. Use with caution in patients with a history of mental health problems or substance misuse.
Overdose	● In the event of an overdose, immediate medical attention is required. Symptoms of an overdose may include drowsiness, agitation, hyperactivity, abnormal behavior, gastrointestinal symptoms, and seizures.
Mg	10 MG, 18 MG, 25 MG, 40MG, 60 MG, 80 MG, 100 MG
Capsules	28 Capsules